相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC
Itziar Otano et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC
Mehrdad Rakaee et al.
JAMA ONCOLOGY (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
Mehrdad Rakaee et al.
BRITISH JOURNAL OF CANCER (2021)
Pathological features of vessel co-option versus sprouting angiogenesis
Emily Latacz et al.
ANGIOGENESIS (2020)
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Thomas K. Kilvaer et al.
CARCINOGENESIS (2020)
Vessel co-option in cancer
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Mehrdad Rakaee et al.
NEOPLASIA (2019)
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Sigurd M. Hald et al.
CLINICAL LUNG CANCER (2018)
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Mehrdad Rakaee et al.
HUMAN PATHOLOGY (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Thomas Karsten Kilvaer et al.
PLOS ONE (2018)
Non-angiogenic tumours and their influence on cancer biology
Tom Donnem et al.
NATURE REVIEWS CANCER (2018)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Erna-Elise Paulsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Assessing PDL-1 and PD-1 in NoneSmall Cell Lung Cancer: A Novel Immunoscore Approach
Erna-Elise Paulsen et al.
CLINICAL LUNG CANCER (2017)
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
T. Donnem et al.
ANNALS OF ONCOLOGY (2016)
The presence of intraepithelial CD45RO+cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
Thomas K. Kilvaer et al.
BRITISH JOURNAL OF CANCER (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Mehrdad Rakaee et al.
ONCOTARGET (2016)
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
Sigurd M. Hald et al.
BMC CANCER (2015)
Stromal CD8+ T-cell Density-A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer
Tom Donnem et al.
CLINICAL CANCER RESEARCH (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
CD45RO + Memory T Lymphocytes - a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer
Erna-Elise Paulsen et al.
NEOPLASIA (2015)
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
Thomas K. Kilvaer et al.
PLOS ONE (2015)
Stage and tissue-specific prognostic impact of miR-182 in NSCLC
Helge Stenvold et al.
BMC CANCER (2014)
Positive prognostic impact of miR-210 in non-small cell lung cancer
Marte Eilertsen et al.
LUNG CANCER (2014)
Monocarboxylate Transporters 1-4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Marte Eilertsen et al.
PLOS ONE (2014)
High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
Helge Stenvold et al.
BMC CLINICAL PATHOLOGY (2014)
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Tom Donnem et al.
CANCER MEDICINE (2013)
Overexpression of matrix metalloproteinase-7 and-9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome
Helge Stenvold et al.
LUNG CANCER (2012)
Independent and Tissue-Specific Prognostic Impact of miR-126 in Nonsmall Cell Lung Cancer
Tom Donnem et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
Tom Donnem et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
Sigve Andersen et al.
PLOS ONE (2011)
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
Sigve Andersen et al.
PLOS ONE (2011)
Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer
T. Donnem et al.
ANNALS OF ONCOLOGY (2010)
The prognostic value of intraepithelial and stromal CD3-, CD117-and CD138-positive cells in non-small cell lung carcinoma
Khalid Al-Shibli et al.
APMIS (2010)
Prognostic Impact of Notch Ligands and Receptors in Nonsmall Cell Lung Cancer Coexpression of Notch-1 and Vascular Endothelial Growth Factor-A Predicts Poor Survival
Tom Donnem et al.
CANCER (2010)
Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients
Samer Al-Saad et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
Khalid Al-Shibli et al.
HISTOPATHOLOGY (2009)
Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival
Tom Donnem et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes
Peyman Sardari Nia et al.
ANNALS OF THORACIC SURGERY (2008)
The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
S. Al-Saad et al.
BRITISH JOURNAL OF CANCER (2008)
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer
Khalid I. Al-Shibli et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells
Tom Donnem et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer
JT Hu et al.
ONCOGENE (2005)
分享论文
